Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2007
08/08/2007CN101014579A 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and dia
08/08/2007CN101014385A The use of medicinal plants and extracts thereof with growth promoting activity in veterinary medicine and zootechnics
08/08/2007CN101014335A Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels
08/08/2007CN101014329A Method of effectively using medicine and method concerning prevention of side effect
08/08/2007CN101014327A Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases
08/08/2007CN101012281A Recombination expression and application of blood sugar reducing peptide and human albumin
08/08/2007CN101012270A Tanshinone derivative and its application in preparing aldose reduction enzyme inhibitor pharmaceutical
08/08/2007CN101012193A Novel CB 1 receptour inverse agonists
08/08/2007CN101011568A Immuno-modulatory agents with function of preventing and curing type 2 diabetes
08/08/2007CN101011561A Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof
08/08/2007CN101011542A Blood fat lowering composition medicine and its preparation
08/08/2007CN101011539A Traditional Chinese medicine for preventing, treating and reverting diabetes and its complications
08/08/2007CN101011525A Antihyperglycemic hepatoprotective agent
08/08/2007CN101011499A Linaloe leaf extract, pharmaceutical and health care uses thereof
08/08/2007CN101011478A Traditional Chinese medicine composition and its preparation method
08/08/2007CN101011464A Composite propolis soft capsule
08/08/2007CN101011453A Preparation for promoting salivation and its preparation and application
08/08/2007CN101011436A Medical usage of total phytosterone from achyranthes
08/08/2007CN101011424A Composition with anti-oxidation and metabolism-promotion functions
08/08/2007CN101011421A Pollen tablet and its preparing process
08/08/2007CN101011413A Use of hydrogen sulfide and its donor sodium hydrosulfide in the production of medicaments
08/08/2007CN101011405A Pharmaceutical composition for treating ischemic cerebral vascular disease
08/08/2007CN101011375A Combretastatin A-4 eye-using preparation for treating diabetic retinopathy
08/08/2007CN101011373A Pharmaceutical composition containing L-carnitine and preparation method thereof
08/08/2007CN101011361A Dispersible tablet of bendazac lysine and its preparation method
08/08/2007CN101011174A Mineral salt beverage
08/08/2007CN101011157A Food additive and producing process thereof
08/08/2007CN101011155A Cactus beverage with fat-reducing and beauty function
08/08/2007CN101011150A Sugar-free seabuckthorn lozenge and its preparing process
08/08/2007CN101011146A Health food capable of decreasing blood sugar
08/08/2007CN101011118A Infant nutrient honey and processing method thereof
08/08/2007CN101011109A Asterias poultry feed additive
08/08/2007CN101011106A Feed addictive for livestock and fowl and producing process thereof
08/08/2007CN101011095A Megranate tea and its preparing process
08/08/2007CN101011094A Waxberry tea and its preparation method
08/08/2007CN101011091A Fermented tea, extract of fermented tea, composition for inhibiting elevation of blood sugar value, and beverage and foodstuff
08/08/2007CN101011073A Ginko-wheat composite powder and its producing technology
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253284 Chemical compounds
08/07/2007US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
08/07/2007US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders
08/07/2007US7253188 Aminobenzamide derivative
08/07/2007US7253187 Heterocyclic inhibitors of ERK2 and uses thereof
08/07/2007US7253181 β3 adrenergic agonists
08/07/2007US7253179 pyrido[4,3-b]carbazol derivatives; melanin-concentrating hormone (MCH) and somatostatin receptors modulator; eating disorders; obesity; anxiolytic agents; psychological disorders
08/07/2007US7253178 Carboxylic acids
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253168 Substituted 1-benzyl-4-substituted piperazine analogues
08/07/2007US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes.
08/07/2007US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other
08/07/2007US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors
08/07/2007US7252974 Human growth gene and short stature gene region
08/07/2007CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i)
08/07/2007CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/07/2007CA2315397C Arylthiazolidinedione derivatives
08/07/2007CA2289196C Sustained-release delayed gels
08/07/2007CA2092718C Use of protective agents against reactive oxygen species
08/02/2007WO2007087448A1 Spiro imidazole derivatives as ppar modulators
08/02/2007WO2007086799A1 Amide substituted quinolines
08/02/2007WO2007086565A1 Growth hormone secretion regulator
08/02/2007WO2007086545A1 Method for screening cell function regulator
08/02/2007WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
08/02/2007WO2007085593A1 Method to control body weight
08/02/2007WO2007085469A1 Acyclic sulfamide derivatives
08/02/2007WO2007085204A1 γ-BUTYROLACTONE COMPOUNDS, THE PREPARATION METHODS AND MEDICAL USES THEREOF
08/02/2007WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
08/02/2007WO2007085202A1 Oxamic acid derivatives,preparation methods and medical uses thereof
08/02/2007WO2007070667A3 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof
08/02/2007WO2007065808A3 Neuropeptide-2 receptor-agonists
08/02/2007WO2007055743A3 Treatment of obesity and related disorders
08/02/2007WO2007047724A3 Compositions for lowering serum cholesterol and/or triglycerides
08/02/2007WO2007047722A3 Methods for treating disorders associated with hyperlipidemia in a mammal
08/02/2007WO2007045927A3 Therapeutic agent
08/02/2007WO2007024863A3 Methods and formulations for modulating lyn kinase activity and treating related disorders
08/02/2007WO2006112549A8 Fused heterocyclic compound
08/02/2007WO2006037501A9 Alkil-pyridines as 11-beta inhibitors for diabetes
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
08/02/2007US20070179154 Coumarin derivatives, process for their production and use thereof
08/02/2007US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007US20070179120 Hydroxyl compounds and compositions for cholesterol management and related uses
08/02/2007US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example
08/02/2007US20070179099 Methods of cholesterol reduction using isoflavones
08/02/2007US20070179097 GnRH agonist combination drugs
08/02/2007US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders
08/02/2007US20070178177 Beverage and medicament containing bamboo extract as a main ingredient
08/02/2007US20070178175 Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
08/02/2007US20070178118 Physiologically active composition and preparing method thereof
08/02/2007US20070178086 Monoclonal antibody against ABCA1
08/02/2007DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases
08/02/2007CA2640141A1 Acyclic sulfamide derivatives
08/02/2007CA2636447A1 Method to control body weight